NEW DATA EVALUATING THE BOSTON SCIENTIFIC ELUVIA™ DRUG-ELUTING VASCULAR STENT SYSTEM DEMONSTRATE 94.4 PERCENT PRIMARY PATENCY RATE AT NINE MONTHS - Hear from Professor Stefan Müller-Hülsbeck, M.D., PhD, MAJESTIC trial principal investigator
Hear from Professor Stefan Müller-Hülsbeck, M.D., PhD, MAJESTIC trial principal investigator